Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Allergy Clin Immunol ; 116(2): 445-52, 2005 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16083804

RESUMO

BACKGROUND: IgE antibody-producing B cells are enriched in the nasal mucosa in patients with allergic rhinitis because of local class switching to IgE. The expressed IgE VH genes also undergo somatic hypermutation in situ to generate clonal families. The antigenic driving force behind these events is unknown. OBJECTIVE: To examine the possible involvement of a superantigen in allergic rhinitis, we compared the variable (VH) gene use and patterns of somatic mutation in the expressed IgE heavy-chain genes in nasal biopsy specimens and blood from allergic patients and the IgA VH use in the same biopsy specimens and also those from nonallergic controls. METHODS: We extracted mRNA from the nasal biopsy specimens of 13 patients and 4 nonallergic control subjects and PBMCs from 7 allergic patients. IgE and IgA VH regions were RT-PCR amplified, and the DNA sequences were compared with those of control subjects. We constructed a molecular model of VH5 to locate amino acids of interest. RESULTS: We observed a significantly increased frequency of IgE and IgA VH5 transcripts in the nasal mucosa of the allergic patients compared with the normal PBMC repertoire. Within IgE and IgA VH5 sequences in the nasal mucosa, the distribution of replacement amino acids was skewed toward the immunoglobulin framework regions. Three of 4 nonintrinsic hotspots of mutation identified in the VH5 sequences were in framework region 1. The hotspots and a conserved VH5-specific framework residue form a tight cluster on the surface of VH5. CONCLUSION: Our results provide evidence for the activity of a superantigen in the nasal mucosa in patients with allergic rhinitis.


Assuntos
Linfócitos B/imunologia , Imunoglobulina E/genética , Cadeias Pesadas de Imunoglobulinas/genética , Região Variável de Imunoglobulina/genética , Mucosa Nasal/imunologia , Rinite Alérgica Perene/imunologia , Rinite Alérgica Sazonal/imunologia , Adolescente , Adulto , Feminino , Humanos , Imunoglobulina A/genética , Imunoglobulina E/química , Cadeias Pesadas de Imunoglobulinas/química , Região Variável de Imunoglobulina/química , Masculino , Pessoa de Meia-Idade , Mutação
2.
J Immunol ; 174(8): 5024-32, 2005 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-15814733

RESUMO

IgE-expressing B cells are over 1000 times more frequent in the nasal B cell than the peripheral blood B cell population. We have investigated the provenance of these B cells in the nasal mucosa in allergic rhinitis. It is generally accepted that expression of activation-induced cytidine deaminase and class switch recombination (CSR) occur in lymphoid tissue, implying that IgE-committed B cells must migrate through the circulation to the nasal mucosa. Our detection of mRNA for activation-induced cytidine, multiple germline gene transcripts, and epsilon circle transcripts in the nasal mucosa of allergic, in contrast to nonallergic control subjects, however, indicates that local CSR occurs in allergic rhinitis. The germline gene transcripts and epsilon circle transcripts in grass pollen-allergic subjects are up-regulated during the season and also when biopsies from allergic subjects are incubated with the allergen ex vivo. These results demonstrate that allergen stimulates local CSR to IgE, revealing a potential target for topical therapies in allergic rhinitis.


Assuntos
Alérgenos/administração & dosagem , Switching de Imunoglobulina , Imunoglobulina E/genética , Mucosa Nasal/imunologia , Rinite Alérgica Perene/genética , Rinite Alérgica Perene/imunologia , Rinite Alérgica Sazonal/genética , Rinite Alérgica Sazonal/imunologia , Adulto , Linfócitos B/enzimologia , Linfócitos B/imunologia , Linfócitos B/patologia , Sequência de Bases , Estudos de Casos e Controles , Citidina Desaminase , Citosina Desaminase/genética , Citosina Desaminase/metabolismo , DNA Complementar/genética , Feminino , Humanos , Técnicas In Vitro , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Mucosa Nasal/enzimologia , Mucosa Nasal/patologia , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Rinite Alérgica Perene/enzimologia , Rinite Alérgica Perene/patologia , Rinite Alérgica Sazonal/enzimologia , Rinite Alérgica Sazonal/patologia , Homologia de Sequência do Ácido Nucleico
3.
Lancet ; 363(9409): 608-15, 2004 Feb 21.
Artigo em Inglês | MEDLINE | ID: mdl-14987885

RESUMO

BACKGROUND: Allergic diseases are frequent and rising in prevalence, and result from activation of T-helper (Th) 2 cells by allergens. CD4+CD25+ regulatory T cells suppress T-cell activation in vitro and prevent pathological findings in animal models of disease. We aimed to investigate whether the amount of inhibition of allergic responses by CD4+CD25+ T cells was related to atopy and allergic disease. METHODS: Blood CD4+CD25+ and CD4+CD25- T cells were isolated from three groups of donors: non-atopic individuals; those atopic with no present symptoms; and patients with hayfever studied during and out of the grass-pollen season. We investigated the ability of CD25+ T cells from these donors to suppress allergen-stimulated T-cell proliferation and cytokine production in vitro. FINDINGS: CD4+CD25+ T cells from non-atopic donors suppressed proliferation and interleukin 5 production by their own allergen-stimulated CD4+CD25- T cells. Inhibition of proliferation by CD4+CD25+ T cells from atopic donors was significantly reduced (p=0.0012), and was even more diminished by CD4+CD25+ T cells isolated from patients with hayfever during the pollen season (p=0.0003). In patients with hayfever, out-of-season suppression remained less than that seen by regulatory cells from non-atopic donors. INTERPRETATION: Allergic disease can result from an inappropriate balance between allergen activation of regulatory CD4+CD25+ T cells and effector Th2 cells. This imbalance could result from a deficiency in suppression by regulatory T cells or strong activation signals could overcome such regulation. Treatment to enhance regulatory T-cell responses, in concert with reduction of Th2 cell activation, might be useful in prevention and treatment of allergic disease.


Assuntos
Alérgenos/imunologia , Antígenos CD4/imunologia , Hipersensibilidade/imunologia , Ativação Linfocitária/imunologia , Receptores de Interleucina-2/imunologia , Fatores Supressores Imunológicos/imunologia , Linfócitos T/imunologia , Adulto , Linfócitos T CD4-Positivos/imunologia , Células Cultivadas , Técnicas de Cocultura , Citocinas/biossíntese , Feminino , Citometria de Fluxo , Humanos , Masculino , Pessoa de Meia-Idade , Linfócitos T Auxiliares-Indutores/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...